Literature DB >> 17287425

Presentation of the Goodpasture autoantigen requires proteolytic unlocking steps that destroy prominent T cell epitopes.

Juan Zou1, Lorna Henderson, Vicky Thomas, Patricia Swan, A Neil Turner, Richard G Phelps.   

Abstract

The most abundant autoreactive T cells in patients with Goodpasture's disease are specific for peptides in the autoantigen that have high affinity for the disease-associated HLA class II molecule, DR15. How can such T cells escape self-tolerance mechanisms? This study showed that these peptides are highly susceptible to destruction in the earliest stages of antigen processing, and some must be cleaved for antigen digestion to be possible ("unlocking"). Goodpasture autoantigen [collagen alpha3(IV)NC1; approximately 31 kD] that was incubated with B cell lysosomes was cleaved within a few minutes to form approximately 9- and approximately 22-kD fragments, then increasing quantities of smaller peptides. The processing was completely abrogated by pepstatin A, a specific inhibitor of cathepsin D/E, even though lysosomal extracts contain a rich array of proteases. Purified cathepsin D generated the same major alpha3(IV)NC1 fragments as entire lysosomes, suggesting that cathepsin D cleavages are required to initiate alpha3(IV)NC1 processing. The initial unlocking cleavages destroyed two major self-epitopes, and subsequent preferred cleavages destroyed all of the other T cell epitopes that are recognized by most patients' autoreactive T cells. The responses of T cell clones that are specific for a major disease-associated peptide to antigen-pulsed intact antigen-presenting cells were substantially enhanced by pepstatin A treatment. Therefore, cathepsin D activity significantly diminishes presentation of alpha3(IV)NC1 peptides that are recognized by patients' T cells by destroying the peptides in early processing. These observations can explain why the mature T cell repertoire includes reactivity toward these self-peptides and suggests that a key factor in disease initiation is likely to be a shift in antigen processing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17287425     DOI: 10.1681/ASN.2006091056

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  12 in total

1.  Phagosomal proteolysis in dendritic cells is modulated by NADPH oxidase in a pH-independent manner.

Authors:  Joanna M Rybicka; Dale R Balce; Sibapriya Chaudhuri; Euan R O Allan; Robin M Yates
Journal:  EMBO J       Date:  2011-12-13       Impact factor: 11.598

2.  Healthy individuals have Goodpasture autoantigen-reactive T cells.

Authors:  Juan Zou; Sigrid Hannier; Lindsay S Cairns; Robert N Barker; Andrew J Rees; A Neil Turner; Richard G Phelps
Journal:  J Am Soc Nephrol       Date:  2008-01-23       Impact factor: 10.121

Review 3.  Sulphilimine cross-links in Goodpasture's disease.

Authors:  R Vanacore; V Pedchenko; G Bhave; B G Hudson
Journal:  Clin Exp Immunol       Date:  2011-05       Impact factor: 4.330

4.  Asymptomatic autoantibodies associate with future anti-glomerular basement membrane disease.

Authors:  Stephen W Olson; Charles B Arbogast; Thomas P Baker; David Owshalimpur; David K Oliver; Kevin C Abbott; Christina M Yuan
Journal:  J Am Soc Nephrol       Date:  2011-08-25       Impact factor: 10.121

Review 5.  Advances in human antiglomerular basement membrane disease.

Authors:  Zhao Cui; Ming-Hui Zhao
Journal:  Nat Rev Nephrol       Date:  2011-07-19       Impact factor: 28.314

Review 6.  Goodpasture's autoimmune disease - A collagen IV disorder.

Authors:  Vadim Pedchenko; A Richard Kitching; Billy G Hudson
Journal:  Matrix Biol       Date:  2018-05-12       Impact factor: 11.583

7.  The HLA-DRB1*15:01-restricted Goodpasture's T cell epitope induces GN.

Authors:  Joshua D Ooi; Janet Chang; Kim M O'Sullivan; Vadim Pedchenko; Billy G Hudson; Arthur A Vandenbark; Lars Fugger; Stephen R Holdsworth; A Richard Kitching
Journal:  J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 10.121

8.  Identification of critical residues of linear B cell epitope on Goodpasture autoantigen.

Authors:  Xiao-yu Jia; Zhao Cui; Jian-nan Li; Shui-yi Hu; Ming-hui Zhao
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

9.  The pathogenicity of T cell epitopes on human Goodpasture antigen and its critical amino acid motif.

Authors:  Shui-Yi Hu; Qiu-Hua Gu; Jia Wang; Miao Wang; Xiao-Yu Jia; Zhao Cui; Ming-Hui Zhao
Journal:  J Cell Mol Med       Date:  2017-03-10       Impact factor: 5.310

10.  Cerebral involvement in a patient with Goodpasture's disease due to shortened induction therapy: a case report.

Authors:  Christoph Preul; Jens Gerth; Sebastian Lang; Christoph Bergmeier; Otto W Witte; Gunter Wolf; Christoph Terborg
Journal:  J Med Case Rep       Date:  2009-11-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.